Recombinant Human MAGEA3
Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Recombinant Human MAGEA3
category
Proteins and Peptides
provider
FineTest
reference
P1396
tested applications
Western Blot, ELISA
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | 1-145 |
| Host | E.Coli |
| Origin | Human |
| Observed MW | 36.4 kDa |
| Expression | Recombinant |
| Purity | Greater than 95% by SDS-PAGE gel analyses |
| Purification | IF2DI tag |
| Size 1 | 50μg |
| Size 2 | 200μg |
| Size 3 | 1mg |
| Form | Lyophilized from a 0.2um filtered solution in PBS with 5% trehalose, pH7.4 |
| Tested Applications | Western Blot, ELISA |
| Buffer | Reconstitute with Sterile distilled water |
| Availability | 7 days |
| Storage | -20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution |
| UniProt ID | P43357 |
| Alias | Antigen MZ2 D, Antigen MZ2-D, Cancer/testis antigen 1.3, Cancer/testis antigen family 1 member 3, CT1.3, HIP8, HYPD, MAGA3_HUMAN, MAGE 3 antigen, MAGE family member A3, MAGE-3 antigen, MAGE3, MAGEA3, MAGEA6, Melanoma antigen family A 3, Melanoma associated antigen 3, Melanoma-associated antigen 3, MGC1461 |
| Background | Proteins MAGEA3 |
| Status | RUO |
| Note | This product is for research use only. |
Related Products
Human MAGEA3(Melanoma-associated antigen 3) ELISA Kit
Ver Producto
anti- MAGEA3 antibody
Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme(E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes.
Ver Producto